Ultragenyx Pharmaceutical (RARE) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.33
-2.23
-2.14
-2.04

Details

Expected EPS
-2.07
Actual EPS
-2.23
Surprise EPS
-0.16
Surprise Percent
+7.73%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.23 per share for Q4 2023.

0 Comments

Share your thoughts